Show simple item record

dc.contributor.authorFulton, J
dc.contributor.authorLamarca, Angela
dc.contributor.authorNuttall, Christina
dc.contributor.authorMcCallum, Lynne
dc.contributor.authorPihlak, Rille
dc.contributor.authorO'Reilly, D
dc.contributor.authorLalloo, F
dc.contributor.authorMcNamara, Mairead G
dc.contributor.authorHubner, Richard A
dc.contributor.authorClancy, T
dc.contributor.authorValle, Juan W
dc.date.accessioned2019-03-29T14:22:35Z
dc.date.available2019-03-29T14:22:35Z
dc.date.issued2019en
dc.identifier.citationFulton A, Lamarca A, Nuttall C, McCallum L, Pihlak R, O'Reilly D, et al. Identification of patients with pancreatic adenocarcinoma due to inheritable mutation: challenges of daily clinical practice. World J Gastrointest Oncol. 2019 Feb 15;11(2):102-16.en
dc.identifier.pmid30788038en
dc.identifier.doi10.4251/wjgo.v11.i2.102en
dc.identifier.urihttp://hdl.handle.net/10541/621705
dc.description.abstractBACKGROUND: Identification of germ-line mutations in pancreatic ductal adenocarcinoma (PDAC) could impact on patient/family. AIM: To assess the referral pathways for genetic consultations in PDAC. METHODS: Electronic records of PDAC patients were reviewed retrospectively. Patients eligible for genetic consultation referral were identified following the European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer (EUROPAC) criteria. RESULTS: Four-hundred patients were eligible. Of 113 patients (28.3%) meeting EUROPAC criteria, 8.8% were referred for genetic opinion. Germ-line mutations were identified in 0.75% of the whole population. CONCLUSION: Earlier referrals and increased awareness may be able to overcome the low rate of successful genetic appointments. KEYWORDS: BRCA; Genetic consultation; Genetic counselling; Germline; Pancreatic adenocarcinomaen
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.4251/wjgo.v11.i2.102en
dc.titleIdentification of patients with pancreatic adenocarcinoma due to inheritable mutation: challenges of daily clinical practiceen
dc.typeArticleen
dc.contributor.departmentCleveland Clinic Taussig Cancer Institute, Clevelanden
dc.identifier.journalWorld Journal of Gastrointestinal Oncologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record